Category: Consumer goods
Quick infos Headquarters: Netherlands Trade prices Volume: Market Cap: 1.19B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: July 26, 2021
Earnings History Date EPS / Forecast Revenue / Forecast November 2, 2021 July 26, 2021 8.51 / 2.94463.87M / 190.02MBeat! May 10, 2021 -0.91 / -0.8935454K / 2.27MBeat! March 17, 2021 - / -0.8691- / 120.05MMarch 1, 2021 -0.01 / -0.852534.19M / 120.05Mview more
Historical Data Date Price Open High Low Vol Change ER Sep 7, 2021 34.84 34.48 35.00
33.98
676.05K 11.99% Sep 3, 2021 31.11 31.25 31.48
30.74
487.31K -0.58% Sep 2, 2021 31.29 29.70 31.41
29.51
720.17K 6.18% Sep 1, 2021 29.47 29.24 30.08
28.73
730.19K 1.62% Aug 31, 2021 29.00 28.69 29.70
28.69
563.60K 1.01% Aug 30, 2021 28.71 29.52 29.85
28.70
408.69K -2.25% Aug 27, 2021 29.37 28.48 29.55
28.46
420.37K 3.31% Aug 26, 2021 28.43 28.84 28.99
28.03
250.51K -1.28% Aug 25, 2021 28.80 28.63 28.96
28.03
375.44K 2.31% Aug 24, 2021 28.15 28.75 28.75
27.30
320.24K 0.39% view more
News
uniQure Stock Is Higher After Investigators Conclude Its Gene Therapy Treatment Was Unlikely to Have Caused a Patients Cancer barrons.com Apr 5, 2021 3:05 pm UniQure's stock rallies 7% on positive safety data for Huntington's disease treatment marketwatch.com Apr 5, 2021 2:03 pm UniQure Hemophilia Therapy Placed on FDA Clinical Hold thestreet.com Apr 5, 2021 10:18 am
uniQure to Participate in Multiple Upcoming Industry Conferences in November finance.yahoo.com Apr 5, 2021 7:05 am
uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program finance.yahoo.com Apr 5, 2021 7:05 am
uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntingtons Disease finance.yahoo.com Apr 5, 2021 7:05 am
Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives investors.com Apr 1, 2021 4:24 pm
Were Hedge Funds Right About Piling Into Uniqure NV (QURE)? finance.yahoo.com Apr 1, 2021 3:44 pm
No Safety Concerns Observed In Uniqure's Early-Stage Huntington's Gene Therapy Study, DSMB Says finance.yahoo.com Apr 1, 2021 9:57 am
Uniqure's Hemophilia B Gene Therapy Unlikely To Be Cause Of Liver Cancer Reported In One Patient finance.yahoo.com Apr 1, 2021 9:26 am
Is uniQure's (NASDAQ:QURE) 128% Share Price Increase Well Justified? finance.yahoo.com Mar 31, 2021 8:06 am
Biotech Stock Pops After Gene Therapy Acquitted In Cancer Diagnosis investors.com Mar 29, 2021 4:06 pm
Is uniQure (NASDAQ:QURE) Using Debt Sensibly? finance.yahoo.com Feb 10, 2021 5:22 am
The Bullish Piece Of News That Caused This Gene Therapy Stock To Pop investors.com Feb 8, 2021 4:40 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE finance.yahoo.com Jan 6, 2021 10:45 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE finance.yahoo.com Dec 29, 2020 8:45 pm
QURE INVESTIGATION: Bronstein, Gewirtz & Grossman, LLC Announces uniQure N.V. Investigation finance.yahoo.com Dec 23, 2020 11:00 am
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress finance.yahoo.com Apr 5, 2021 7:05 am
uniQure Announces Findings from Reported Case of Hepatocellular Carcinoma (HCC) in Hemophilia B Gene Therapy Program finance.yahoo.com Apr 5, 2021 7:05 am
uniQure Announces Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntingtons Disease finance.yahoo.com Apr 5, 2021 7:05 am Key Persons Talk about uniQure NV below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
